HARBERT FUND ADVISORS, INC. - Q4 2020 holdings

$132 Million is the total value of HARBERT FUND ADVISORS, INC.'s 18 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .

 Value Shares↓ Weighting
ENZ  ENZO BIOCHEM INC$14,164,000
+19.4%
5,620,6810.0%10.73%
-26.0%
QUMU  QUMU CORP$10,927,000
+73.3%
1,367,5220.0%8.28%
+7.5%
STRM  STREAMLINE HEALTH SOLUTIONS$5,213,0000.0%3,341,6370.0%3.95%
-38.0%
LNDC  LANDEC CORP$3,245,000
+11.6%
299,1160.0%2.46%
-30.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
I3 VERTICALS INC23Q2 202443.3%
ENZO BIOCHEM INC23Q2 202430.1%
STREAMLINE HEALTH SOLUTIONS23Q2 20246.4%
TRANSACT TECHNOLOGIES INC21Q2 20245.3%
QUMU CORP17Q4 20228.3%
IDENTIV INC16Q2 20247.7%
TURTLE BEACH CORP14Q2 20249.1%
VSE CORP13Q3 20235.2%
ACCURAY INC13Q2 20244.1%
FENNEC PHARMACEUTICALS INC13Q2 20243.6%

View HARBERT FUND ADVISORS, INC.'s complete holdings history.

Latest significant ownerships (13-D/G)
HARBERT FUND ADVISORS, INC. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Global Indemnity Group, LLCOctober 28, 2022324,7643.0%

View HARBERT FUND ADVISORS, INC.'s complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR/A2024-01-26
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14

View HARBERT FUND ADVISORS, INC.'s complete filings history.

Compare quarters

Export HARBERT FUND ADVISORS, INC.'s holdings